Showing results (341-350 of 1,162) with videos related to
Sort By:
Pageof 117
Cell Metabolism|April 4, 2006
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesionsSeongah Han, Chien-Ping Liang, Tracie DeVries-Seimon, et al.Cell Reports|May 31, 2016
Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin ResistanceLale Ozcan, Devram S Ghorpade, Ze Zheng, et al.Journal of Lipid Research|October 15, 2022
Dennd5b-Deficient Mice are Resistant to PCSK9-Induced Hypercholesterolemia and Diet-Induced Hepatic SteatosisMaura Mobilia, Callie Whitus, Alexander Karakashian, et al.Journal of Lipid Research|August 15, 2002
Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphologyStewart C Whitman, Debra L Rateri, Stephen J Szilvassy, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2017
Sex Chromosome Complement Defines Diffuse Versus Focal Angiotensin II-Induced Aortic PathologyYasir Alsiraj, Sean E Thatcher, Eric Blalock, et al.BMC Cardiovascular Disorders|October 20, 2017
Deletion of the NR4A nuclear receptor NOR1 in hematopoietic stem cells reduces inflammation but not abdominal aortic aneurysm formationHua Qing, Karrie L Jones, Elizabeth B Heywood, et al.Scientific Reports|June 20, 2020
Circadian disruption with constant light exposure exacerbates atherosclerosis in male ApolipoproteinE-deficient miceJeffrey M Chalfant, Deborah A Howatt, Lisa R Tannock, et al.British Journal of Pharmacology|January 19, 2005
Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysmsLisa A Cassis, Marc J Helton, Deborah A Howatt, et al.Global Translational Medicine|July 21, 2025
Hepatocyte-specific angiotensinogen deficiency inhibits Western diet-induced liver steatosis with suppression of cell division in miceAlex C Pettey, Dien Ye, Sohei Ito, et al.Innate Immunity|May 29, 2012
The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout miceM Rachel Richards, Audrey S Black, David J Bonnet, et al.Pageof 117